BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
search help

Documents 1-20 out of 20 found
  Current Search:  renagel: 484, sevelamer: 49, hydrochloride: 3359  

100%
TEXT
http://www.fda.gov/cder/orange/appendix_a.txt
4, ACETAMINOPHEN PHENAPHEN-650 W/ CODEINE, ACETAMINOPHEN PHENAZINE, PHENDIMETRAZINE TARTRATE PHENAZINE-35, PHENDIMETRAZINE TARTRATE PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE PHENERGAN FORTIS, PROMETHAZINE HYDROCHLORIDE PHENERGAN PLAIN, PROMETHAZINE HYDROCHLORIDE PHENERGAN VC W/ CODEINE, CODEINE PHOSPHATE PHENERGAN VC, PHENYLEPHRINE HYDROCHLORIDE PHENERGAN W...

Matching: renagel sevelamer hydrochloride Find similar documents More document info
100%
HTML
Prescription and Over-the-Counter Drug Product List: 4/2003
45 -D- XCEL PHARMS 1MG/ML N05929 001 APR CFTG -A- AP + 1MG/ML N05929 001 APR CFTG -A- DIHYDROEROGTAMINE MESYLATE -A- AP PADDOCK 1MG/ML N40475 001 APR 28, 2003 APR NEWA DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE; ORAL -A- TAZTIA XT -A- AB4 ANDRX PHARMS 120MG N75401 001 APR 10, 2003 APR NEWA -A- AB4 180MG N75401 002 APR 10, 2003 APR NEWA -A- AB4 240MG N75401 003 APR 10,...
author: AUTHOR
Matching: renagel sevelamer hydrochloride Find similar documents More document info
100%
HTML
Prescription and OTC Drug Product List 10/1998
Prescription and Over-the-Counter Drug Product List - 18th Edition Cumulative Supplement Number 10: October 1998 [ Prescription - OTC ] ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; BUTALBITAL; CAFFEINE BENZYL PENICILLOYL-POLYLYSINE CAPSULE; ORAL INJECTABLE; INJECTION BUTALBITAL, ACETAMINOPHEN AND CAFFEINE PRE-PEN - ADD - AB WEST WARD 500MG;50MG;40MG N40261...
Matching: renagel sevelamer hydrochloride Find similar documents More document info
100%
HTML
FDA Drug Approvals List July 2000
- Drug Approvals for July 2000 Definitions and Notes Original New Drug Applications Original Application #: 050779 Approval Date: 27-JUL-00 Trade Name: CEFAZOLIN AND DEXTROSE Chemical Type: 5 Therapeutic Potential: S Dosage Form: INJECTABLE Applicant: B BRAUN MEDICAL INC Active Ingredient(s): CEFAZOLIN SODIUM OTC/RX Status: RX Indication(s): For the treatment of respiratory tract...
Matching: renagel sevelamer hydrochloride Find similar documents More document info
100%
PDF
Geltex Report Template
Sevelamer hydrochloride is poly( allylamine hydrochloride) crosslinked with epichlorohydrin in which forty percent of the amines are protonated
Sevelamer hydrochloride is hydrophilic, but insoluble in water
The structure is represented below: Chemical Structure of Sevelamer Hydrochloride NH 2 °nHCl NH° nHCl OH NH 2 °nHCl NH° nHCl c a...

author: Debra Sojka
Matching: renagel sevelamer hydrochloride Find similar documents More document info

100%
PDF
Geltex Report Template page 1


author: Debra Sojka
Matching: renagel sevelamer hydrochloride Find similar documents More document info

100%
HTML
FDA Drug Approvals List- October 1998
Drug Approvals for October 1998 Definitions and Notes October 1998 Original New Drug Applications Original Application #: 020926 Approval Date: 30-OCT-98 Trade Name: RENAGEL Chemical Type: 1 Therapeutic Potential: S Dosage Form: CAPSULE Applicant: GELTEX PHARMACEUTICALS INC Active Ingredient(s): SEVELAMER HYDROCHLORIDE OTC/RX Status: RX Indication(s): For the...
Matching: renagel sevelamer hydrochloride Find similar documents More document info
75%
HTML
Nabi Biopharmaceuticals - Product Publications
PRODUCTS Products Overview PhosLo® Nabi-HB® WinRho SDF® Aloprim™ Plasma Products -----Antibody Plasma -----Products -----Plasma Centers Product Publications Material Safety Data Sheets - Product Publications If you wish to receive a copy of any of the following publications, please contact Nabi Biopharmaceuticals Medical...
Matching: renagel sevelamer Find similar documents More document info
75%
PDF
PDF cover 0509.qxd
This weeks UK PDJ reported the entry into force of the SPC for Chiron's humanised monoclonal antibody treatment for breast cancer, trastuzumab, "as present in the EMEA approved product Herceptin ®", which is based on EP153114.
According to our Strategic Drugs Database (SDdb) sevelamer hydrochloride (Renagel) is indicated for the control of serum phosphate levels in...

author: LEmson
Matching: renagel sevelamer Find similar documents More document info

75%
PDF
PDF cover 0509.qxd page 1


author: LEmson
Matching: renagel sevelamer Find similar documents More document info

75%
PDF
Approved Products_2004.xls
Number A pproval Date Trade Name Generic/ Chemical name Indication Company 1 Oct- 82 Humulin Human Insulin Type I Diabetes Lilly / Genentech 2 Oct- 85 Protro pin Human Growth Hormone Hypoptuitary dwarfism Genentech 3 Jun- 86 Intron A Interferon Al pha 2B Hairy Cell Leukemia Schering Plough / Biogen 4 Jun- 86 OKT- 3 Anti CD3 Mab Acute Trans plant Rejection JNJ / OrthoBiotech 5 Jun- 86...

author: Reijer
Matching: renagel sevelamer Find similar documents More document info

75%
PDF
Approved Products_2004.xls page 3


author: Reijer
Matching: renagel sevelamer Find similar documents More document info

75%
PDF
http://www.anormed.com/documents/foz_renagel.pdf
Presented at the ISN/ ASN World Congress of Nephrology October 2001, San Francisco ][ A3863] Effects of the Phosphate Binder Renagel® (Sevelamer) on Biochemical Parameters and Bone Histology in a Chronic Renal Failure (CRF) Rat Model
D'Haese; Dept of Nephrology, University of Antwerp, Belgium Date/ Time: Tuesday, October 16, 2001 10: 00 AM Location: Halls A/ B/ C...

Matching: renagel sevelamer Find similar documents More document info

75%
PDF
Geltex Report Template page 6


author: Debra Sojka
Matching: renagel sevelamer Find similar documents More document info

75%
PDF
20926LBL.PDF
Page 1 2.1 PACKAGE INSERT (LOGO) Renagel® Capsules (sevelamer hydrochloride) 403 mg Renagel ® Capsules (sevelamer hydrochloride) [se vel¢ ¢ a mer] DESCRIPTION Renagel * Capsules contain sevelamer hydrochloride, a polymeric phosphate binder intended for oral administration
Sevelamer hydrochloride is poly( allylamine hydrochloride)...

author: Unknown
Matching: renagel sevelamer Find similar documents More document info

75%
PDF
20926LBL.PDF page 4


author: Unknown
Matching: renagel sevelamer Find similar documents More document info

75%
PDF
20926LBL.PDF page 1


author: Unknown
Matching: renagel sevelamer Find similar documents More document info

67%
HTML
Information Meeting on New Product
Information Meeting on New Product Presentations- The Positioning of Capecitabine for Breast Cancer Masanori Nishida Medical Business & Science Dept
1 - ( 417KB ) Sevelamer Hydrochloride Fumio Ishihata Medical Business & Science Dept
2 - ( 422KB ) Date- July 4, 2003 In order to view the PDF files, you will need to download the Acrobat Reader Copyright(c) 2003 Chugai...
Matching: sevelamer hydrochloride Find similar documents More document info
67%
HTML
EFFICACY SUPPLEMENTS APPROVED IN CY 2000
Also, under GRANULES FOR ORAL SUSPENSION in the DOSAGE AND ADMINISTRATION section, the age range for children in the dosing tables was expanded to -age 5 months through 12 years.- SOTALOL HYDROCHLORIDE BERLEX LABS 21-151 22-Jun-98 22-Feb-00 N 000 N 20.1 Provides for the new indication of prolongation of time to recurrence of symptomatic AFIB/AFL in patients with symptomatic...
Matching: sevelamer hydrochloride Find similar documents More document info
58%
HTML
What's new at CDER by Date
New and Generic Drug Approvals Benazepril Hydrochloride Tablets, Mylan Pharmaceuticals Benazepril Hydrochloride Tablets, Ranbaxy Benazepril Hydrochloride Tablets, Andrx Pharmaceuticals Benazepril Hydrochloride Tablets, Genpharm Benazepril Hydrochloride Tablets, Ivax Pharmaceuticals Benazepril Hydrochloride Tablets, Teva Pharmaceuticals Benazepril ...
author: Paul Stauffer
Matching: renagel hydrochloride Find similar documents More document info

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.